Product Details
Product Name:
CAY10595 |
CAS No.:
916047-16-0 |
Purity:
99.71% |
Supply Ability:
10g |
Release date:
2024/11/19 |
Product Introduction
Bioactivity
Name | CAY10595 |
Description | CAY10595 is an antagonist of the CRTh2 (DP2) receptor with a Ki of 10 nM. |
In vivo | CAY10595 slightly delays the development of CIA and reduces IgG2a anti-CII levels without modification of the levels of IgG anti-CII[2]. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 50 mg/mL (110.81 mM)
|
Keywords | CAY 10595 | CAY-10595 | CAY10595 |
Inhibitors Related | Vincamine | Ramatroban | Monomethyl fumarate | Questiomycin A | 3-Hydroxyoctanoic Acid | CRTh2 antagonist 2 | Fezagepras sodium | Benzyl nicotinate | 1-methoxycyclopropanecarboxylic acid | TUG-1375 | Timapiprant | NF-56-EJ40 |
Related Compound Libraries | Bioactive Compound Library | Membrane Protein-targeted Compound Library | Inhibitor Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:223387-75-5
$33.00 / 2mg
-
CAS:115416-38-1
$43.00 / 5mg
-
CAS:1850276-58-2
$58.00 / 1mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$46.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |